. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/economicsAntipsychotic Agents/therapeutic useAnxietyAripiprazoleDopamine Agonists/pharmacokineticsDopamine Agonists/pharmacologyDrug InteractionsFees, PharmaceuticalHumansIntestinal Absorption/physiologyNausea/chemically inducedPiperazines/adverse effectsPiperazines/pharmacokineticsPiperazines/therapeutic useQuinolones/adverse effectsQuinolones/pharmacokineticsQuinolones/therapeutic useRandomized Controlled Trials as TopicSchizophrenia/drug therapyTherapeutic Equivalency
Substances： See more » Antipsychotic AgentsDopamine AgonistsPiperazinesQuinolonesAripiprazole
Year: 2003 PMID： 12592215
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN： 0025-732X Impact factor: 1.909